<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIM: <z:hpo ids='HP_0002633'>Vasculitis</z:hpo> is a clinical, pathologic process characterized by <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mp ids='MP_0001651'>necrosis</z:mp> of blood vessel occuring anywhere in the body </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the study was to present some clinical and immunologic features of <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> in <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic diseases</z:e>: <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, multiple <z:mp ids='MP_0000612'>sclerosis</z:mp>, <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e>, <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's diseases</z:e>, and others </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A total of 1 254 peatients with <z:hpo ids='HP_0000554'>uveitis</z:hpo> were included in the study </plain></SENT>
<SENT sid="3" pm="."><plain>The immunochemical diagnostic methods were used to determine the pathogenesis of ocular manifestations </plain></SENT>
<SENT sid="4" pm="."><plain>Ocular manifestations were examined using biomicroscope, direct or indirect ophtalmoscopy </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Primary <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> was diagnosed in 85/1254 (6.8%) of total <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>In more than half of the cases of <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (58.8%), both arteries and veins were involved in inflammatory process </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0031129" disease_type="Disease or Syndrome" abbrv="">Periphlebitis</z:e> was diagnosed far more commonly (36.5%) than <z:e sem="disease" ids="C0264988" disease_type="Disease or Syndrome" abbrv="">periarteritis</z:e> (4.7%) </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="46" ids="15035">Retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> associated with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> was characterized by microinfarctions and the consequent foci of inflammatory cells or diseases of large arteries manifesting in vasospasm and occlusions </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0271053" disease_type="Disease or Syndrome" abbrv="">Cotton wool spots</z:e> occured in 38.3% and <z:hpo ids='HP_0000573'>retinal hemorrhages</z:hpo> in 34% of the cases </plain></SENT>
<SENT sid="10" pm="."><plain>In this study <z:e sem="disease" ids="C0031129" disease_type="Disease or Syndrome" abbrv="">periphlebitis</z:e> of the retina was one of the less frequent ocular manifestations of multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Comparing with the other changes of the <z:chebi fb="46" ids="15035">retinal</z:chebi> blood vessels, venous sheating occured in 25.1% and occlusion and vein <z:mp ids='MP_0005048'>thrombosis</z:mp> in 43.75% of the cases </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="46" ids="15035">Retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> associated with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> occured in 37.5% of patients with <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>The most frequent manifestation of <z:e sem="disease" ids="C0398677" disease_type="Disease or Syndrome" abbrv="">ocular sarcoidosis</z:e> was intermediary <z:hpo ids='HP_0000554'>uveitis</z:hpo> (43.75%) </plain></SENT>
<SENT sid="14" pm="."><plain>Anterior granulomatous <z:hpo ids='HP_0000554'>uveitis</z:hpo> occured in 37.5% of patients with <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidoses</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>Immune complexes occured in 13/20 (65%) of the patients </plain></SENT>
<SENT sid="16" pm="."><plain>Antiretinal anti-S antibody in the serum occured in 73% of the patients with <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> as a complication of <z:e sem="disease" ids="C0277554" disease_type="Disease or Syndrome" abbrv="">primary disease</z:e> and in 25% those with <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="17" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">Systemic diseases</z:e> such as <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's syndrome</z:e>, <z:e sem="disease" ids="C0262428" disease_type="Disease or Syndrome" abbrv="">collagen vascular diseases</z:e>, systemic <z:e sem="disease" ids="C0740451" disease_type="Disease or Syndrome" abbrv="">granulomatous diseases</z:e> (<z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> and <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e>) were the main causes of <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="18" pm="."><plain>Knowledge of the symptomatology and pathogenesis of <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> is of the major significance for the diagnosis and therapy of the disease </plain></SENT>
</text></document>